{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:24:05Z","timestamp":1770740645434,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.drugalcdep.2015.09.001","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T13:19:09Z","timestamp":1441631949000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners"],"prefix":"10.1016","volume":"156","author":[{"given":"Frank J.","family":"Vocci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy W.","family":"Kinlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence T.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050559","article-title":"Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans","volume":"136","author":"Amass","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison \u2013 a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1360-0443.2003.00264.x","article-title":"Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996\u201399","volume":"98","author":"Bird","year":"2003","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0025","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","article-title":"Methadone treatment of randomly selected criminal addicts","volume":"280","author":"Dole","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.1990.67","article-title":"Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal","volume":"47","author":"Fudala","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/ADM.0b013e31814b8880","article-title":"Buprenorphine-naloxone treatment for pre-release opioid-dependent inmate in Puerto Rico","volume":"1","author":"Garcia","year":"2007","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0050","series-title":"The War on Drugs III","author":"Inciardi","year":"2008"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.1989.66","article-title":"Sublingual versus subcutaneous buprenorphine in opiate abusers","volume":"45","author":"Jasinski","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.1989.147","article-title":"Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction","volume":"46","author":"Johnson","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0070","series-title":"Opioid Substitution Treatment in Custodial Settings. A Practical Guide","author":"Kastelic","year":"2008"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1081\/ADA-200056804","article-title":"A novel opioid maintenance program for prisoners: report of post-release outcomes","volume":"31","author":"Kinlock","year":"2005","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10509670903534951","article-title":"Developing and implementing a new prison-based buprenorphine treatment program","volume":"49","author":"Kinlock","year":"2010","journal-title":"J. Offender Rehabil."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months post-release","volume":"37","author":"Kinlock","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release","volume":"91","author":"Kinlock","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the addiction severity index. Reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ADT.0b013e3182133949","article-title":"An adverse reaction to buprenorphine\/naloxone induction in prison: a case report","volume":"10","author":"Rich","year":"2011","journal-title":"Addict. Disord. Their Treat."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment","volume":"87","author":"Springer","year":"2010","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0125","doi-asserted-by":"crossref","first-page":"e38335","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"Springer","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.drugpo.2006.11.015","article-title":"The impact of substitution treatment in prisons \u2013 a literature review","volume":"18","author":"Stallwitz","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1467-842X.2004.tb00629.x","article-title":"Risk of death in prisoners after release from jail","volume":"28","author":"Stewart","year":"2004","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002130050066","article-title":"Effects of buprenorphine versus buprenorphine\/naloxone tablets in non-dependent opioid abusers","volume":"148","author":"Strain","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0145","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.001_bib0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"Zaller","year":"2013","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161501621X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161501621X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:23:04Z","timestamp":1537363384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161501621X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":31,"alternative-id":["S037687161501621X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}